Sintx Technologies Stock to Reverse Split on Tuesday, May 28th (NASDAQ:SINT)

Sintx Technologies, Inc. (NASDAQ:SINTFree Report) shares are scheduled to reverse split on Tuesday, May 28th. The 1-200 reverse split was announced on Tuesday, May 28th. The number of shares owned by shareholders will be adjusted after the market closes on Tuesday, May 28th.

Sintx Technologies Stock Down 13.5 %

Sintx Technologies stock opened at $0.08 on Friday. The company has a market cap of $9.83 million, a price-to-earnings ratio of -0.04 and a beta of 1.39. The firm’s fifty day moving average is $0.06 and its 200 day moving average is $0.22. Sintx Technologies has a 52-week low of $0.02 and a 52-week high of $1.82.

Sintx Technologies (NASDAQ:SINTGet Free Report) last released its quarterly earnings results on Wednesday, March 27th. The company reported ($0.09) earnings per share (EPS) for the quarter. Sintx Technologies had a negative net margin of 318.99% and a negative return on equity of 81.96%. The business had revenue of $0.90 million for the quarter.

Analysts Set New Price Targets

Separately, Maxim Group reissued a “hold” rating on shares of Sintx Technologies in a research note on Monday, February 5th.

View Our Latest Research Report on SINT

Institutional Investors Weigh In On Sintx Technologies

A hedge fund recently bought a new stake in Sintx Technologies stock. Anson Funds Management LP purchased a new position in Sintx Technologies, Inc. (NASDAQ:SINTFree Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 959,297 shares of the company’s stock, valued at approximately $47,000. Anson Funds Management LP owned about 4.23% of Sintx Technologies at the end of the most recent quarter. Institutional investors own 18.38% of the company’s stock.

About Sintx Technologies

(Get Free Report)

Sintx Technologies, Inc, an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone.

Featured Articles

Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.